Liabilities / Assets
18th percentile
Higher debt load relative to assets than 18% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
18th percentile
Higher debt load relative to assets than 18% of similar nonprofits.
Liabilities / Revenue
12th percentile
Higher debt load relative to revenue than 12% of similar nonprofits.
Net Margin
42nd percentile
Higher net margin than 42% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
43rd percentile
Faster asset growth than 43% of similar nonprofits.
Revenue Growth
99th percentile
Faster revenue growth than 99% of similar nonprofits.
Assets
Up$5,332,454
Up $4,154 (+0.1%) from 2015
Net Assets
Up$5,262,518
Up $9,755 (+0.2%) from 2015
Liabilities
Down$69,936
Down $5,601 (-7.4%) from 2015
Revenue
Up$4,175,464
Up $3,623,358 (+656%) from 2015
Expenses
Up$4,165,709
Up $1,806,930 (+77%) from 2015
Net Income
Up$9,755
Up $1,816,428 (+101%) from 2015
This 2016 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Charley's fund's singular mission is to support the development of treatments and a cure for duchenne muscular dystrophy (dmd). We identify and direct funding to the most compelling research and treatment programs related to dmd and, (cont. On sch. O.)
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2016 • Form 990Summary only. Only limited summary data is available for this year.